Invokana® Lawsuit Update

An Invokana lawsuit will move a at a brisk pace thanks to a recent court order. Recently, Judge Brian Martinotti, issued Case Management Order Number 4 regarding the filing of Invokana amputation and ketoacidosis lawsuits. In the order, Judge Martinott granted Invokana victim’s the right to directly file their lawsuit in MDL 2750, In Re: Invokana Products Liability Litigation, Case Number 3:16-md-2750.  To accomplish this, cases directly filed with the MDL court must follow the following:

•  Cases must utilize a particular caption;
•  The case must contain a statement indicating that it is being filed in accordance with CMO No. 4;
•  The case must designate the venue, which will be the place of remand;
•  The case must be filed electronically.

This is a great development for Invokana plaintiffs as it will substantially reduce the amount of time incurred for the case to be filed and docketed with the MDL. The first bellwether trial is set to start in September 2018.

What is an Invokana Lawsuit Injury Case?

Generally, an Invokana injury lawsuit involves a diabetic who is using Invokana and suffers the loss of a limb, such as a foot, ankle or leg. Also, claims involve diabetic ketoacidosis, kidney failure and death.

The Invokana Timeline

•  March, 2013: Entered the market; in the March, 2013;
•  December, 2015: Diabetic ketoacidosis was added to the Warnings & Precaution Section of the label;
•  June 2016: Kidney failure warning was added to the Warnings & Precaution Section of the label;
•  August 2016: Diabetic ketoacidosis warning was amended to include reports of “Fatal” Diabetic Ketoacidosis;
•  May 2017: Black Boxed Warning for amputation was added to the label.
•  To date Invokana has grossed close to $5 Billion dollars for Janssen Pharmaceuticals.

Questions About Invokana Lawsuits?

The James Esparza Law Firm is here to answer your questions about Invokana lawsuits. Call Now 1-800-745-4050.